Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
Saar Gill, Carl H. June
Immunological Reviews (2014) Vol. 263, Iss. 1, pp. 68-89
Closed Access | Times Cited: 309

Showing 1-25 of 309 citing articles:

Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg, Nicholas P. Restifo
Science (2015) Vol. 348, Iss. 6230, pp. 62-68
Open Access | Times Cited: 2200
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey, Nicholas D. Huntington, Mark J. Smyth
Nature Immunology (2016) Vol. 17, Iss. 9, pp. 1025-1036
Closed Access | Times Cited: 980
Advances in Biomaterials for Drug Delivery
Owen S. Fenton, Katy N. Olafson, Padmini S. Pillai, et al.
Advanced Materials (2018) Vol. 30, Iss. 29
Open Access | Times Cited: 731
TGFβ biology in cancer progression and immunotherapy
Rik Derynck, Shannon J. Turley, Rosemary J. Akhurst
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 1, pp. 9-34
Open Access | Times Cited: 647
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Martin P. Stewart, Róbert Langer, Klavs F. Jensen
Chemical Reviews (2018) Vol. 118, Iss. 16, pp. 7409-7531
Open Access | Times Cited: 596
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Kole T. Roybal, Jasper Z. Williams, Leonardo Morsut, et al.
Cell (2016) Vol. 167, Iss. 2, pp. 419-432.e16
Open Access | Times Cited: 587
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang, Yiran Zheng, Mariane B. Melo, et al.
Nature Biotechnology (2018) Vol. 36, Iss. 8, pp. 707-716
Open Access | Times Cited: 555
Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
Axel Hoos
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 4, pp. 235-247
Closed Access | Times Cited: 551
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah, Meng-Yin Lin, Anne Silva-Benedict, et al.
Cancer Immunology Research (2016) Vol. 4, Iss. 6, pp. 498-508
Open Access | Times Cited: 532
Chimeric antigen receptor T-cell therapies for lymphoma
Jennifer N. Brudno, James N. Kochenderfer
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 1, pp. 31-46
Closed Access | Times Cited: 462
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Élodie Picarda, Kim C. Ohaegbulam, Xingxing Zang
Clinical Cancer Research (2016) Vol. 22, Iss. 14, pp. 3425-3431
Open Access | Times Cited: 459
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams, James Smothers, Roopa Srinivasan, et al.
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 9, pp. 603-622
Closed Access | Times Cited: 432
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Gregory L. Beatty, Mark H. O’Hara, Simon F. Lacey, et al.
Gastroenterology (2018) Vol. 155, Iss. 1, pp. 29-32
Open Access | Times Cited: 419
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
Katherine G. MacDonald, Romy E. Hoeppli, Qing Huang, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 4, pp. 1413-1424
Open Access | Times Cited: 406
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Lindsay K. Ward-Kavanagh, Wai Lin, John R. Šedý, et al.
Immunity (2016) Vol. 44, Iss. 5, pp. 1005-1019
Open Access | Times Cited: 389
New development in CAR-T cell therapy
Zhenguang Wang, Zhiqiang Wu, Yang Liu, et al.
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 345
Efficient Nanovaccine Delivery in Cancer Immunotherapy
Guizhi Zhu, Fuwu Zhang, Qianqian Ni, et al.
ACS Nano (2017) Vol. 11, Iss. 3, pp. 2387-2392
Closed Access | Times Cited: 321
Present and future therapies of hepatitis B: From discovery to cure
T. Jake Liang, Timothy M. Block, Brian J. McMahon, et al.
Hepatology (2015) Vol. 62, Iss. 6, pp. 1893-1908
Open Access | Times Cited: 298
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang, Pranav Oberoi, Sarah Oelsner, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 276
The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden
Bianca Santomasso, Carlos Bachier, Jason R. Westin, et al.
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. 433-444
Closed Access | Times Cited: 267
T cell metabolic fitness in antitumor immunity
Peter J. Siska, Jeffrey C. Rathmell
Trends in Immunology (2015) Vol. 36, Iss. 4, pp. 257-264
Open Access | Times Cited: 265
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Siwei Wang, Chao Gao, Yi-Min Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 260
Driving gene-engineered T cell immunotherapy of cancer
Laura A. Johnson, Carl H. June
Cell Research (2016) Vol. 27, Iss. 1, pp. 38-58
Open Access | Times Cited: 243
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Blythe Sather, Guillermo S. Romano Ibarra, Karen Sommer, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 307
Open Access | Times Cited: 219
Progress and challenges in viral vector manufacturing
Johannes C.M. van der Loo, J. Fraser Wright
Human Molecular Genetics (2015) Vol. 25, Iss. R1, pp. R42-R52
Open Access | Times Cited: 210
Page 1 - Next Page

Scroll to top